메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한내과학회 대한내과학회지 대한내과학회지 제87권 제5호
발행연도
2014.1
수록면
521 - 529 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Cancer, including gastric cancer, occurs predominantly in older patients. Although there is no single internationally acceptedstandard chemotherapy regimen for unresectable or metastatic gastric cancer (MGC), doublet combination chemotherapy using fluoropyrimidineand platinum is regarded as the reference treatment. However, most of the clinical trials that were based on the currenttreatment guidelines were performed in patients < 70 years of age with good performance status (PS). Therefore, the clinicalapplication of these guidelines to elderly individuals is limited. The available data suggest that older patients with good PS are ableto tolerate the same chemotherapy regimens as younger patients with MGC, and that they achieve a similar efficacy. In contrast,some studies showed that the same efficacy was achieved at the expense of increased toxicity in older patients, emphasizing the importanceof patient selection. Many studies have actively investigated elderly patients with MGC, including randomized phase 3studies comparing fluoropyrimidine and platinum doublets with fluoropyrimidine alone. Although an advanced age alone shouldnot preclude the use of effective chemotherapy in MGC, more data regarding age-specific clinical trials are needed to guide optimaltreatment in elderly patients.

목차

등록된 정보가 없습니다.

참고문헌 (22)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0